AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
The below-mentioned stocks have witnessed substantial growth in their share prices today (8 February 2019). Let's take a closer look at these stock -
Hot Chili Limited (ASX:HCH)
Leading copper developer, Hot Chili Limited (ASX:HCH) has recently announced its intention to undertake a non-renounceable rights issue of two fully paid ordinary shares in the Company for every 7 fully paid ordinary shares in the Company held at 11 February 2019 at an offer price of $0.01 per New Share, to raise up to $2,216,979 (before costs). Moreover, the company has recently announced that it had successfully arranged a $1 million (before costs) private placement of fully paid ordinary shares in the Company (to various sophisticated and professional investors in Australia, and to investors in other jurisdictions, at an issue price of $0.01 per Placement Share.Â
The Funds from the Placement and Rights Issue will be used for general working capital requirements and these funds will allow Hot Chili Limited to focus on preparations to start drilling in key areas of the Cortadera discovery while also advancing its project-level, strategic funding discussions with key stakeholders regarding the proposed Carola transaction.
On 4 February 2019, the company executed a formal Option Agreement to fully acquire a mining right, clearing a path for consolidation of entire Cortadera copper-gold discovery in Chile.
As at 31 December 2018, the company had cash and cash equivalent of A$701k. In the past six months, the share price of the company decreased by 40.74% as on 7 February 2019. HCHâs shares traded at $0.017 (+6.25% intraday) with a market capitalization of circa $12.42 million as on 8 February 2019. It has a 52-week high of $0.037 and 52 weeks low of $0.009.
Contango Asset Management Limited (ASX:CGA)
Financial services company, Contango Asset Management Limited (ASX:CGA) reported Revenue from ordinary activities $13,036k for FY18 which was 214.3 percent higher than the previous year. In the financial year 2018, the consolidated profit of the Group amounted to $3,462 k with basic earnings per share of 8.8 cents. At the end of FY 2018, the company had total current assets of $7,784 k and total current liabilities of $1,417 k.
In November 2018, the company announced the resignation of Hari Morfis as Company Secretary. For the December quarter, the company reported net cash used in operating activities of A$406k. As at 31 December 2018, the company had cash and cash equivalent of A$4,229k.
Now let us quickly have a glance at Contango Asset Management Limitedâs stock performance. In the past six months, the share price of the company decreased by 61.02 percent as on 7 February 2019. CGAâs shares traded at $0.275 (+19.565% intraday) with a market capitalization of circa $11.29 million as on 8 February 2019.
Rhythm Biosciences Limited (ASX:RHY)
Australian Medical diagnostics company, Rhythm Biosciences Limited (ASX:RHY) has recently received ethics approval for a 1,000-patient prospective clinical trial of its blood test ColoSTAT® for the early detection of colorectal cancer. The company is expecting to sign the first clinical trial site in the coming months as planned and other Melbourne sites to come on board soon thereafter. Recently, the company welcomed the Australian governmentâs announcement by Minister for Health, Greg Hunt, to invest $10 million on an education campaign for the National Bowel Cancer Screening Program. In December, the company received $283,796 from the Companyâs R&D Tax Incentive claim for FY 2018.
In FY 2018, the company reported a Comprehensive Loss of $1,753,480 with basic and diluted loss per share of 2.25 cents. At the end of FY18, the company reported current assets of $7,869,277 and current liabilities of $147,379.
Now let us quickly have a glance at Rhythm Biosciences Limitedâs stock performance and the return it has posted in the last few months. The stock last traded at a price of $0.145 and increased by almost 11.538% during the intraday trade. The stock has generated a negative YTD return of 7.14% and posted negative returns of 18.75%, 16.13% and 7.14% over the last six months, three months and one-month, respectively. It has a 52-week high price of $0.270 and a 52-week low of $0.127, with an average trading volume of ~119,906.
Disclaimer
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.
